{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T04:12:32Z","timestamp":1750997552872,"version":"3.41.0"},"reference-count":20,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780443218682"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.mcb.2024.02.037","type":"book-chapter","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T13:18:06Z","timestamp":1710163086000},"page":"213-228","source":"Crossref","is-referenced-by-count":0,"title":["Flow cytometry conjugate formation assay between natural killer cells and their target cells"],"prefix":"10.1016","author":[{"given":"Gilles","family":"Iserentant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Seguin-Devaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7118-6944","authenticated-orcid":false,"given":"Jacques","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.mcb.2024.02.037_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107658","article-title":"A natural product, piperlongumine (PL), increases tumor cells sensitivity to NK cell killing","volume":"96","author":"Afolabi","year":"2021","journal-title":"International Immunopharmacology"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0015","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1073\/pnas.0607418104","article-title":"Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell\/target cell contact","volume":"104","author":"Back","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0020","series-title":"Natural killer cell protocols","first-page":"89","article-title":"Natural killer cell conjugate assay using two-color flow cytometry","volume":"Vol. 612","author":"Burshtyn","year":"2010"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0025","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0030","doi-asserted-by":"crossref","first-page":"1199594","DOI":"10.3389\/fimmu.2023.1199594","article-title":"NK cells in peripheral blood carry trogocytosed tumor antigens from solid cancer cells","volume":"14","author":"Campos-Mora","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0035","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends in Immunology"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","article-title":"Harnessing innate immunity in cancer therapy","volume":"574","author":"Demaria","year":"2019","journal-title":"Nature"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0045","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ygyno.2018.12.023","article-title":"MUC16 suppresses human and murine innate immune responses","volume":"152","author":"Felder","year":"2019","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0050","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The broad spectrum of human natural killer cell diversity","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0055","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/scd.2019.0059","article-title":"Differential immunomodulatory effects of human bone marrow-derived mesenchymal stromal cells on natural killer cells","volume":"28","author":"Hu","year":"2019","journal-title":"Stem Cells and Development"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0060","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1002\/ijc.22579","article-title":"Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells","volume":"120","author":"Jarahian","year":"2007","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.intimp.2018.12.020","article-title":"Direct potentiation of NK cell cytotoxicity by 8-azaguanine with potential antineoplastic activity","volume":"67","author":"Kim","year":"2019","journal-title":"International Immunopharmacology"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcp.30921","article-title":"Identification of a novel mechanism for LFA-1 organization during NK cytolytic response","volume":"238","author":"Pariani","year":"2023","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0075","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/eji.200838863","article-title":"Statins inhibit NK-cell cytotoxicity by interfering with LFA-1-mediated conjugate formation","volume":"39","author":"Raemer","year":"2009","journal-title":"European Journal of Immunology"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41586-021-04142-6","article-title":"Untimely TGF\u03b2 responses in COVID-19 limit antiviral functions of NK cells","volume":"600","author":"Witkowski","year":"2021","journal-title":"Nature"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0085","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.molimm.2018.08.015","article-title":"Impaired cytolytic activity of asthma-associated natural killer cells is linked to dysregulated transcriptional program in energy metabolism","volume":"101","author":"Wu","year":"2018","journal-title":"Molecular Immunology"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0090","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.4049\/jimmunol.1501284","article-title":"A heterozygous RAB27A mutation associated with delayed cytolytic granule polarization and hemophagocytic lymphohistiocytosis","volume":"196","author":"Zhang","year":"2016","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0095","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000348","article-title":"CD56dimCD16dim natural killer (NK) cells: The forgotten population","volume":"4","author":"Zimmer","year":"2020","journal-title":"HemaSphere"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.187.1.117","article-title":"Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome)","volume":"187","author":"Zimmer","year":"1998","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/bs.mcb.2024.02.037_bb0105","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1084\/jem.194.10.1531","article-title":"H-2D ligand expression by Ly49A+ natural killer (NK) cells precludes ligand uptake from environmental cells: Implications for NK cell function","volume":"194","author":"Zimmer","year":"2001","journal-title":"The Journal of Experimental Medicine"}],"container-title":["Methods in Cell Biology","The Immunological Synapse - Part C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X24000682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091679X24000682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T16:27:13Z","timestamp":1750955233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091679X24000682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443218682"],"references-count":20,"URL":"https:\/\/doi.org\/10.1016\/bs.mcb.2024.02.037","relation":{},"ISSN":["0091-679X"],"issn-type":[{"type":"print","value":"0091-679X"}],"subject":[],"published":{"date-parts":[[2025]]}}}